Israel Bacteriophages Therapy Market to 2032
Overview
The Israel Bacteriophages Therapy Market is expected to reach a 0.13 USD Million by 2032 and is projected to grow at a CAGR of 6.14% from 2025 to 2032.
Revenue, 2024 (USD Million)
0.09
Forecast, 2032 (USD Million)
0.13
CAGR, 2024 - 2032
6.14%
Report Coverage
Israel
Israel Bacteriophages Therapy Market 2018-2032 USD Million
Israel Bacteriophages Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 0.09 USD Million
- Projected Market Size (2032): 0.13 USD Million
- CAGR (2025-2032): 6.14%
Key Findings of Israel Bacteriophages Therapy Market
- The Israel Bacteriophages Therapy Market was valued at 0.09 USD Million in 2024.
- The Israel Bacteriophages Therapy Market is likely to grow at a CAGR of 6.14% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 0.09 USD Million
- The fastest growing segment Escherichia coli in Target Segment grew Fastest with a CAGR of 6.80% during the forecast period from 2024 to 2032.
Israel Bacteriophages Therapy Market Scope
Israel Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Type
- Lysogenic
- Lytic
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Israel Bacteriophages Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 0.09 USD Million |
| Market Value in 2032 | 0.13 USD Million |
| CAGR (2025-2032) | 6.14% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target |
Regional Insights:
-
Leading Market (2024-2032): Israel, leading in terms of revenue 0.09 USD Million in 2024
- Key Country: Israel, leading in terms of revenue with value of 0.09 USD Million in 2024.
Segments and Scope
-
Israel Bacteriophages Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.08 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 6.22 % in forecast period 2025-2032.
-
Israel Bacteriophages Therapy Market to 2032, By End User
- Hospitals is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.04 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 5.78 % in forecast period 2025-2032.
-
Israel Bacteriophages Therapy Market to 2032, By Route Of Administration
- Oral is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.04 USD Million in the year 2024.
- Dermal is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 5.75 % in forecast period 2025-2032.
-
Israel Bacteriophages Therapy Market to 2032, By Application
- Postoperative Wound Infections is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.03 USD Million in the year 2024.
- Supperative Skin Infections is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 6.55 % in forecast period 2025-2032.
-
Israel Bacteriophages Therapy Market to 2032, By Base
- Sterile Broth Culture is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.07 USD Million in the year 2024.
- Sterile Broth Culture is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 6.35 % in forecast period 2025-2032.
-
Israel Bacteriophages Therapy Market to 2032, By Type
- Lytic is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.09 USD Million in the year 2024.
- Lytic is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 6.18 % in forecast period 2025-2032.
-
Israel Bacteriophages Therapy Market to 2032, By Target
- Staphylococcus is the largest segment in Israel Bacteriophages Therapy Market to 2032 with a revenue of 0.03 USD Million in the year 2024.
- Escherichia coli is the Fastest growing segment in Israel Bacteriophages Therapy Market to 2032 with a Growth rate of 5.78 % in forecast period 2025-2032.
Israel Bacteriophages Therapy Market Company Share Analysis
| Company Name |
|
||
| Microgen | |||
| MICREOS | |||
| Intralytix, Inc. | |||
| LOCUS BIOSCIENCES, INC. | |||
| Phagelux, Inc. | |||
Israel Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
Israel Bacteriophages Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Israel Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
Israel Bacteriophages Therapy Market was valued at USD 0.09(Revenue in USD Million) in 2020.
Israel Bacteriophages Therapy Market is projected to grow at a CAGR of 6.14% during the forecast period of 2024 to 2032.
The Lytic segment is expected to dominate the Israel Bacteriophages Therapy Market, holding a largest market share of 0.09 USD Million in 2024
Israel Bacteriophages Therapy Market Scope
Israel Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Type
- Lysogenic
- Lytic
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Frequently Asked Questions
The Israel Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
Israel Bacteriophages Therapy Market was valued at USD 0.09(Revenue in USD Million) in 2020.
Israel Bacteriophages Therapy Market is projected to grow at a CAGR of 6.14% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Bacteriophages Therapy Market for final year is USD 0.13 (USD Million).
Israel Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The Israel Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
Israel Bacteriophages Therapy Market was valued at USD 0.09(Revenue in USD Million) in 2020.
Israel Bacteriophages Therapy Market is projected to grow at a CAGR of 6.14% during the forecast period of 2024 to 2032.
The estimated market value of the Israel Bacteriophages Therapy Market for final year is USD 0.13 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.